EMvision Accounts Payable vs Short Long Term Debt Total Analysis

EMV Stock   1.88  0.05  2.59%   
EMvision Medical financial indicator trend analysis is much more than just examining EMvision Medical Devices latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether EMvision Medical Devices is a good investment. Please check the relationship between EMvision Medical Accounts Payable and its Short Long Term Debt Total accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EMvision Medical Devices. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Accounts Payable vs Short Long Term Debt Total

Accounts Payable vs Short Long Term Debt Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of EMvision Medical Devices Accounts Payable account and Short Long Term Debt Total. At this time, the significance of the direction appears to have almost no relationship.
The correlation between EMvision Medical's Accounts Payable and Short Long Term Debt Total is 0.16. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Short Long Term Debt Total in the same time period over historical financial statements of EMvision Medical Devices, assuming nothing else is changed. The correlation between historical values of EMvision Medical's Accounts Payable and Short Long Term Debt Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of EMvision Medical Devices are associated (or correlated) with its Short Long Term Debt Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Long Term Debt Total has no effect on the direction of Accounts Payable i.e., EMvision Medical's Accounts Payable and Short Long Term Debt Total go up and down completely randomly.

Correlation Coefficient

0.16
Relationship DirectionPositive 
Relationship StrengthInsignificant

Accounts Payable

An accounting item on the balance sheet that represents EMvision Medical obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of EMvision Medical Devices are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Short Long Term Debt Total

Most indicators from EMvision Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into EMvision Medical Devices current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EMvision Medical Devices. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, EMvision Medical's Tax Provision is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 16 M in 2024, whereas Selling General Administrative is likely to drop slightly above 1.5 M in 2024.
 2021 2022 2023 2024 (projected)
Depreciation And Amortization243.3K342.0K410.6K390.1K
Interest Income15.6K35.3K341.2K358.3K

EMvision Medical fundamental ratios Correlations

0.970.610.980.67-0.98-0.89-0.221.00.820.551.00.890.80.860.750.861.00.820.880.780.860.970.890.940.76
0.970.580.950.5-0.93-0.82-0.180.960.810.660.960.920.750.780.650.860.970.880.80.670.950.980.850.960.76
0.610.580.460.36-0.57-0.760.250.630.70.00.630.820.730.660.650.90.610.430.720.620.40.480.730.370.95
0.980.950.460.71-0.99-0.84-0.30.980.780.590.980.790.740.840.720.750.980.820.840.760.850.970.850.970.64
0.670.50.360.71-0.77-0.78-0.410.720.58-0.050.720.370.660.790.840.440.680.30.780.840.250.550.70.540.38
-0.98-0.93-0.57-0.99-0.770.890.24-0.99-0.81-0.5-0.99-0.82-0.79-0.89-0.79-0.79-0.99-0.79-0.9-0.83-0.78-0.94-0.9-0.92-0.71
-0.89-0.82-0.76-0.84-0.780.890.28-0.91-0.9-0.13-0.91-0.81-0.93-0.92-0.94-0.87-0.89-0.6-0.95-0.89-0.64-0.79-0.94-0.73-0.83
-0.22-0.180.25-0.3-0.410.240.28-0.21-0.220.09-0.210.06-0.39-0.25-0.40.04-0.21-0.01-0.18-0.23-0.17-0.27-0.22-0.320.16
1.00.960.630.980.72-0.99-0.91-0.210.820.511.00.880.810.870.780.861.00.780.890.810.820.950.90.920.76
0.820.810.70.780.58-0.81-0.9-0.220.820.220.820.760.890.930.890.80.810.780.950.820.710.760.970.710.85
0.550.660.00.59-0.05-0.5-0.130.090.510.220.510.520.090.19-0.080.330.560.760.20.070.770.70.270.740.23
1.00.960.630.980.72-0.99-0.91-0.211.00.820.510.880.810.870.780.861.00.780.890.810.820.950.90.920.76
0.890.920.820.790.37-0.82-0.810.060.880.760.520.880.750.710.60.980.890.760.760.610.830.860.80.790.91
0.80.750.730.740.66-0.79-0.93-0.390.810.890.090.810.750.840.90.810.790.590.90.880.580.730.930.670.81
0.860.780.660.840.79-0.89-0.92-0.250.870.930.190.870.710.840.940.750.850.710.970.850.620.770.960.730.77
0.750.650.650.720.84-0.79-0.94-0.40.780.89-0.080.780.60.90.940.690.750.490.940.90.450.630.910.580.71
0.860.860.90.750.44-0.79-0.870.040.860.80.330.860.980.810.750.690.850.660.80.670.730.790.830.70.95
1.00.970.610.980.68-0.99-0.89-0.211.00.810.561.00.890.790.850.750.850.810.870.780.860.970.890.940.76
0.820.880.430.820.3-0.79-0.6-0.010.780.780.760.780.760.590.710.490.660.810.720.560.890.870.780.870.68
0.880.80.720.840.78-0.9-0.95-0.180.890.950.20.890.760.90.970.940.80.870.720.940.620.780.990.730.83
0.780.670.620.760.84-0.83-0.89-0.230.810.820.070.810.610.880.850.90.670.780.560.940.440.660.90.620.69
0.860.950.40.850.25-0.78-0.64-0.170.820.710.770.820.830.580.620.450.730.860.890.620.440.930.690.920.64
0.970.980.480.970.55-0.94-0.79-0.270.950.760.70.950.860.730.770.630.790.970.870.780.660.930.830.990.68
0.890.850.730.850.7-0.9-0.94-0.220.90.970.270.90.80.930.960.910.830.890.780.990.90.690.830.780.86
0.940.960.370.970.54-0.92-0.73-0.320.920.710.740.920.790.670.730.580.70.940.870.730.620.920.990.780.58
0.760.760.950.640.38-0.71-0.830.160.760.850.230.760.910.810.770.710.950.760.680.830.690.640.680.860.58
Click cells to compare fundamentals

EMvision Medical Account Relationship Matchups

EMvision Medical fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets6.0M10.8M8.5M11.5M24.0M25.2M
Other Current Liab170.1K313.1K478.9K682.7K2.1M2.2M
Total Current Liabilities489.7K676.2K854.0K6.0M3.4M1.9M
Total Stockholder Equity5.5M10.1M7.1M5.1M18.5M19.4M
Net Tangible Assets5.0M9.6M6.6M4.6M5.3M5.6M
Net Debt(5.4M)(9.5M)(6.1M)(6.9M)(15.7M)(14.9M)
Retained Earnings(7.3M)(15.7M)(21.8M)(25.7M)(26.5M)(25.2M)
Accounts Payable319.6K193.7K178.2K330.7K293.5K221.1K
Cash5.4M9.7M6.8M10.0M18.6M19.5M
Non Current Assets Total480.0K798.7K1.4M1.3M2.1M1.1M
Cash And Short Term Investments5.4M9.7M6.8M10.0M18.6M19.5M
Net Receivables81.3K117.4K69.9K2.9M3.4M3.5M
Common Stock Shares Outstanding61.4M70.1M75.2M77.7M80.4M73.8M
Liabilities And Stockholders Equity6.0M10.8M8.5M11.5M24.0M25.2M
Inventory(38.0K)51.1K130.1K5.9K6.8K6.5K
Other Current Assets43.3K285.8K269.8K265.2K463.5K236.5K
Other Stockholder Equity840.6K4.3M5.7M4.5M5.2M2.9M
Total Liab489.7K720.0K1.4M6.4M5.5M5.7M
Total Current Assets5.5M10.0M7.1M10.2M21.9M23.0M
Common Stock12.0M21.4M23.2M26.2M41.6M21.1M
Non Current Liabilities Total43.8K43.8K571.6K365.9K2.0M2.1M
Net Invested Capital5.5M10.1M7.1M7.6M21.1M22.2M
Accumulated Other Comprehensive Income840.6K4.3M5.7M4.5M3.5M3.6M
Capital Stock12.0M21.4M23.2M26.2M41.6M24.2M
Net Working Capital5.0M9.3M6.2M4.2M18.5M19.4M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for EMvision Stock Analysis

When running EMvision Medical's price analysis, check to measure EMvision Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EMvision Medical is operating at the current time. Most of EMvision Medical's value examination focuses on studying past and present price action to predict the probability of EMvision Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EMvision Medical's price. Additionally, you may evaluate how the addition of EMvision Medical to your portfolios can decrease your overall portfolio volatility.